首页 | 本学科首页   官方微博 | 高级检索  
     

脂联素与急性冠脉综合征近期预后的相关性研究
引用本文:毕方杰,牟春平,孔繁和. 脂联素与急性冠脉综合征近期预后的相关性研究[J]. 黑龙江医药科学, 2009, 32(3): 27-28
作者姓名:毕方杰  牟春平  孔繁和
作者单位:佳木斯大学第一附属医院循环内科,黑龙江,佳木斯,154003
摘    要:目的:探讨脂联素(APN)与急性冠脉综合征(ASC)近期预后的相关性研究。方法:选择急性冠脉综合征患者62例。并选取门诊健康查体者20例作为对照组。在患者入院后30d内随访其心血管事件发发生情况,将ASC患者以随访结果分为再发生主要不良心血管事件组(MACE组)和未再发生主要不良心血管事件组(N--MACE组)。结果:ASC组脂联素浓度低于正常对照组脂联素浓度(5.95±0.55.9.35±0.66)mg/L,差异有统计学意义(P〈0.05),比较MACE组和N—MACE组脂联素浓度,前者低于后者(5.75±0.48.6.08±0.56)mg/L,有统计学意义(P〈0.05)。结论:脂联素可能是预测ASC患者预后的有效指标。

关 键 词:脂联素  急性冠脉综合征  预后

The correction between adiponectin and the recent prognosis of acute coronary syndrome
BI Fang-jie,MU Chun-ping,KONG Fan-he. The correction between adiponectin and the recent prognosis of acute coronary syndrome[J]. Heilongjiang Medicine and Pharmacy, 2009, 32(3): 27-28
Authors:BI Fang-jie  MU Chun-ping  KONG Fan-he
Affiliation:The First Affiliated Hospital of Jiamusi University;Jiamusi 154003;China
Abstract:Objective:To explore the correction between adiponectin and the recent prognosis of acute coronary syndrome (ACS). Methods:Patients with ACS (n=62) were divided into two groups according to recurrence of cardiovascular events based on 30 d follow--up and 20 out--patients were selected as control group. The ACS patients were further divided into adverse cardiovascular events (ACE) group and non--adverse cardiovascular events (N--ACE) group, Results:The ACS adiponectin level was lower than that of control group (5.95±0.55,9.35±0.66) mg/L,with a significant difference (P 〈 0.05 ). The adiponeetin level of ACE group in ACS was lower than that of APN than N--ACE group, (5.75±0.48,6.08±0.56)mg/L,with a significant difference (P 〈 0.05). Conclusion:The adiponectin level is associated with short--term prognosis of patients with ACS.
Keywords:adiponectin  ACS  prognosis  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号